FineMark National Bank & Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.41M | Buy |
25,419
+166
| +0.7% | +$30.2K | 0.14% | 128 |
|
|
2025
Q3 | $4.81M | Sell |
25,253
-16,270
| -39% | -$2.89M | 0.16% | 118 |
|
|
2025
Q2 | $7.46M | Sell |
41,523
-370
| -0.9% | -$64.3K | 0.25% | 92 |
|
|
2025
Q1 | $7.09M | Sell |
41,893
-209
| -0.5% | -$34.3K | 0.26% | 95 |
|
|
2024
Q4 | $6.35M | Sell |
42,102
-532
| -1% | -$82.7K | 0.22% | 98 |
|
|
2024
Q3 | $6.62M | Buy |
42,634
+54
| +0.1% | +$8.06K | 0.23% | 97 |
|
|
2024
Q2 | $5.83M | Buy |
42,580
+1,448
| +4% | +$198K | 0.21% | 104 |
|
|
2024
Q1 | $5.48M | Buy |
41,132
+134
| +0.3% | +$17.4K | 0.2% | 105 |
|
|
2023
Q4 | $5.65M | Sell |
40,998
-1,254
| -3% | -$165K | 0.23% | 97 |
|
|
2023
Q3 | $5.15M | Buy |
42,252
+580
| +1% | +$77.3K | 0.22% | 101 |
|
|
2023
Q2 | $5.86M | Buy |
41,672
+85
| +0.2% | +$11.7K | 0.24% | 98 |
|
|
2023
Q1 | $5.88M | Buy |
41,587
+2,540
| +7% | +$363K | 0.25% | 90 |
|
|
2022
Q4 | $6.11M | Buy |
39,047
+1,205
| +3% | +$173K | 0.27% | 88 |
|
|
2022
Q3 | $4.64M | Buy |
37,842
+15,374
| +68% | +$2.02M | 0.22% | 105 |
|
|
2022
Q2 | $2.99M | Buy |
+22,468
| New | +$3.06M | 0.13% | 131 |
|
|
2022
Q1 | – | Sell |
-1,390
| Closed | -$240K | – | 454 |
|
|
2021
Q4 | $240K | Hold |
1,390
| – | – | 0.01% | 412 |
|
|
2021
Q3 | $202K | Buy |
+1,390
| New | +$203K | 0.01% | 424 |
|
|
2018
Q3 | – | Sell |
-3,162
| Closed | -$348K | – | 346 |
|
|
2018
Q2 | $348K | Sell |
3,162
-122
| -4% | -$12.7K | 0.02% | 296 |
|
|
2018
Q1 | $329K | Buy |
+3,284
| New | +$336K | 0.02% | 293 |
|
|
2017
Q1 | – | Sell |
-1,076
| Closed | -$99K | – | 527 |
|
|
2016
Q4 | $99K | Hold |
1,076
| – | – | 0.01% | 467 |
|
|
2016
Q3 | $91K | Hold |
1,076
| – | – | 0.01% | 481 |
|
|
2016
Q2 | $88K | Sell |
1,076
-324
| -23% | -$24.7K | 0.01% | 467 |
|
|
2016
Q1 | $100K | Hold |
1,400
| – | – | 0.01% | 430 |
|
|
2015
Q4 | $100K | Hold |
1,400
| – | – | 0.01% | 441 |
|
|
2015
Q3 | $86K | Hold |
1,400
| – | – | 0.01% | 488 |
|
|
2015
Q2 | $102K | Hold |
1,400
| – | – | 0.01% | 486 |
|
|
2015
Q1 | $108K | Hold |
1,400
| – | – | 0.01% | 470 |
|
|
2014
Q4 | $94K | Hold |
1,400
| – | – | 0.01% | 499 |
|
|
2014
Q3 | $85K | Hold |
1,400
| – | – | 0.01% | 514 |
|
|
2014
Q2 | $82K | Hold |
1,400
| – | – | 0.01% | 514 |
|
|
2014
Q1 | $81K | Sell |
1,400
-9
| -0.6% | -$482 | 0.02% | 494 |
|
|
2013
Q4 | $75K | Buy |
1,409
+9
| +0.6% | +$534 | 0.02% | 495 |
|
|
2013
Q3 | $87K | Hold |
1,400
| – | – | 0.02% | 457 |
|
|
2013
Q2 | $85K | Buy |
+1,400
| New | +$83.4K | 0.03% | 430 |
|
Other funds holding DGX
FineMark National Bank & Trust's DGX Position: Q4 2025 in Review
FineMark National Bank & Trust increased its Quest Diagnostics (DGX) stake by 0.66% in Q4 2025, buying an estimated $30.2K and bringing the position to 25,419 shares worth $4.41M. The position accounts for 0.14% of the portfolio, ranked #128.
FineMark National Bank & Trust first reported a position in DGX in Q2 2013 and has held it in 34 quarters since. The position peaked at $7.46M in Q2 2025. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- FineMark National Bank & Trust held 25,419 shares of Quest Diagnostics worth $4.41M as of Q4 2025.
- FineMark National Bank & Trust bought 166 Quest Diagnostics shares in Q4 2025, an estimated $30.2K.
- Quest Diagnostics made up 0.14% of FineMark National Bank & Trust's portfolio in Q4 2025, its #128 holding.
- FineMark National Bank & Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 34 quarters since.
- FineMark National Bank & Trust's Quest Diagnostics position peaked at $7.46M in Q2 2025.
- 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.